News & Updates

Show Multimedia Only
Does diabetes worsen survival in metastatic breast cancer?

Does diabetes worsen survival in metastatic breast cancer?

19 Sep 2022

Diabetes does not appear to increase mortality in patients with metastatic breast cancer (MBC), but diabetes and hyperglycaemia both contribute to worse overall survival (OS) in a cohort of longer-term survivors, a study has found.

19 Sep 2022
Poststroke statin treatment confers survival benefits for cancer patients

Poststroke statin treatment confers survival benefits for cancer patients

16 Sep 2022

Statin treatment following ischaemic stroke appears to extend its benefits to improved survival in patients who also have had cancer, a study has found.

16 Sep 2022
Proximal gastrectomy OK for proximal advanced gastric cancer

Proximal gastrectomy OK for proximal advanced gastric cancer

16 Sep 2022

For patients with proximal advanced gastric cancer (AGC), proximal gastrectomy (PG) appears to be a reasonable treatment option, particularly for those with small tumours, a recent study has found.

16 Sep 2022
Maximal androgen blockade the prime prostate cancer treatment option in older patients

Maximal androgen blockade the prime prostate cancer treatment option in older patients

16 Sep 2022

Among prostate cancer patients aged ≥75 years, maximal androgen blockage (MAB) appears to be the most common treatment option, reports a new South Korea study. Meanwhile, the combination of leuprolide and bicalutamide is the most common MAB regimen.

16 Sep 2022
First-line rucaparib boosts PFS in ovarian cancer regardless of HRD status

First-line rucaparib boosts PFS in ovarian cancer regardless of HRD status

15 Sep 2022 byRoshini Claire Anthony

First-line rucaparib maintenance therapy extends progression-free survival (PFS) in patients with ovarian, fallopian tube, or primary peritoneal cancer, according to results of the phase III ATHENA-MONO trial presented at the ESMO Gynaecological Cancers Conference 2022.

15 Sep 2022